WallStreetZenWallStreetZen

NASDAQ: NVAX
Novavax Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for NVAX

Based on 5 analysts offering 12 month price targets for Novavax Inc.
Min Forecast
$27.00+60.91%
Avg Forecast
$119.00+609.18%
Max Forecast
$207.00+1,133.61%

Should I buy or sell NVAX stock?

Based on 6 analysts offering ratings for Novavax Inc.
Buy
Strong Buy
2 analysts 33.33%
Buy
2 analysts 33.33%
Hold
0 analysts 0%
Sell
1 analysts 16.67%
Strong Sell
1 analysts 16.67%

Be the first to know when Wall Street analysts revise their NVAX stock forecasts and price targets.

NVAX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
B. Riley Securities
Top 1%
100
Strong BuyMaintains$83.00+394.64%2022-10-14
JP Morgan
Bottom 6%
6
Strong SellDowngrades$27.00+60.91%2022-09-22
Cowen & Co.
Bottom 25%
25
BuyMaintains$110.00+555.54%2022-08-09Find out why
Cantor Fitzgerald
Top 2%
99
Strong BuyMaintains$168.00+901.19%2022-06-08Find out why
Bank of America
Top 23%
78
SellInitiates Coverage OnN/AN/A2022-05-20
HC Wainwright & Co.
Top 9%
92
BuyMaintains$207.00+1,133.61%2022-03-03

1 of 1

Forecast return on equity

Is NVAX forecast to generate an efficient return?
Company
-135.51%
Industry
15.35%
Market
62.84%
NVAX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NVAX forecast to generate an efficient return on assets?
Company
33.83%
Industry
13.55%
NVAX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NVAX earnings per share forecast

What is NVAX's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$20.98
Avg 2 year Forecast
$10.87
Avg 3 year Forecast
$7.04

NVAX revenue forecast

What is NVAX's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$2.2B+17.83%
Avg 2 year Forecast
$3.6B+93.93%
Avg 3 year Forecast
$2.3B+26.8%
NVAX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NVAX revenue growth forecast

How is NVAX forecast to perform vs Biotechnology companies and vs the US market?
Company
15.84%
Industry
24.83%
Market
6.69%
NVAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NVAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NVAX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NVAX$16.78$119.00+609.18%Buy
VERV$21.07$50.25+138.49%Buy
TVTX$20.10$38.80+93.03%Strong Buy
SAVA$33.62$44.00+30.87%Strong Buy
KROS$49.43$90.00+82.08%Strong Buy

Novavax Stock Forecast FAQ

Is Novavax Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: NVAX) stock is to Buy NVAX stock.

Out of 6 analysts, 2 (33.33%) are recommending NVAX as a Strong Buy, 2 (33.33%) are recommending NVAX as a Buy, 0 (0%) are recommending NVAX as a Hold, 1 (16.67%) are recommending NVAX as a Sell, and 1 (16.67%) are recommending NVAX as a Strong Sell.

If you're new to stock investing, here's how to buy Novavax stock.

What is NVAX's earnings growth forecast for 2022-2024?

(NASDAQ: NVAX) Novavax's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Novavax's earnings in 2022 is -$1,321,974,000.On average, 2 Wall Street analysts forecast NVAX's earnings for 2022 to be $1,647,012,913, with the lowest NVAX earnings forecast at $1,347,127,816, and the highest NVAX earnings forecast at $1,946,898,010. On average, 6 Wall Street analysts forecast NVAX's earnings for 2023 to be $853,337,958, with the lowest NVAX earnings forecast at $102,055,138, and the highest NVAX earnings forecast at $2,539,602,847.

In 2024, NVAX is forecast to generate $552,667,822 in earnings, with the lowest earnings forecast at $342,277,231 and the highest earnings forecast at $717,526,121.

What is NVAX's revenue growth forecast for 2022-2024?

(NASDAQ: NVAX) Novavax's forecast annual revenue growth rate of 15.84% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.83%, and while it is forecast to beat the US market's average forecast revenue growth rate of 6.69%.

Novavax's revenue in 2022 is $1,846,673,000.On average, 3 Wall Street analysts forecast NVAX's revenue for 2022 to be $170,814,080,022, with the lowest NVAX revenue forecast at $169,003,307,866, and the highest NVAX revenue forecast at $172,692,993,610. On average, 4 Wall Street analysts forecast NVAX's revenue for 2023 to be $281,139,687,470, with the lowest NVAX revenue forecast at $181,483,081,115, and the highest NVAX revenue forecast at $486,182,825,131.

In 2024, NVAX is forecast to generate $183,820,614,790 in revenue, with the lowest revenue forecast at $160,229,706,190 and the highest revenue forecast at $202,602,999,322.

What is NVAX's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: NVAX) forecast ROA is 33.83%, which is higher than the forecast US Biotechnology industry average of 13.55%.

What is NVAX's Price Target?

According to 5 Wall Street analysts that have issued a 1 year NVAX price target, the average NVAX price target is $119.00, with the highest NVAX stock price forecast at $207.00 and the lowest NVAX stock price forecast at $27.00.

On average, Wall Street analysts predict that Novavax's share price could reach $119.00 by Oct 14, 2023. The average Novavax stock price prediction forecasts a potential upside of 609.18% from the current NVAX share price of $16.78.

What is NVAX's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: NVAX) Novavax's current Earnings Per Share (EPS) is -$17.33. On average, analysts forecast that NVAX's EPS will be $20.98 for 2022, with the lowest EPS forecast at $17.16, and the highest EPS forecast at $24.80. On average, analysts forecast that NVAX's EPS will be $10.87 for 2023, with the lowest EPS forecast at $1.30, and the highest EPS forecast at $32.35. In 2024, NVAX's EPS is forecast to hit $7.04 (min: $4.36, max: $9.14).

What is NVAX's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: NVAX) forecast ROE is -135.51%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.